Patents by Inventor Anthony W. Ford-Hutchinson

Anthony W. Ford-Hutchinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and Methods for Computing Measurements for Mitochondrial Diseases
    Publication number: 20210375467
    Abstract: This disclosure is directed to methods of methods of computing a composite measurement comprising employing two or more sub-instruments to measure one or more clinical symptoms of mitochondrial dysfunction or mitochondrial disease. This disclosure is also directed to methods of assessing and managing a subject with mitochondrial dysfunction or mitochondrial disease using a composite measurement.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 2, 2021
    Applicants: RIBONOVA INC., The Children's Hospital of Philadelphia
    Inventors: Marni J. Falk, Nigel L. Webb, Shana E. McCormack, Eric C. Yuen, Zarazuela Zolkipli-Cunningham, Anthony W. Ford-Hutchinson
  • Methods of Treating Mitochondrial Dysfunction
    Publication number: 20210283072
    Abstract: This disclosure is directed to methods of treating or preventing mitochondrial dysfunction or mitochondrial disease in a subject comprising administration of probucol, or a pharmaceutically acceptable salt thereof. This disclosure is also directed to methods of diagnosing genetic mitochondrial disease in a subject prior to and in association with said treatment or prevention. This disclosure is also directed to methods of assessing and managing a subject with mitochondrial dysfunction or mitochondrial disease using a composite measurement.
    Type: Application
    Filed: June 26, 2019
    Publication date: September 16, 2021
    Applicant: RIBONOVA INC.
    Inventors: Marni J. Falk, Shana E. McCormack, Zaraxuela Zolkipli-Cunningham, Nigel L. Webb, Eric C. Yuen, Anthony W. Ford-Hutchinson
  • Cardiovascular composition
    Patent number: 4558037
    Abstract: A cardiovascular composition is disclosed which comprises either dibenzo-thiepin derivatives alone or the combination of dibenzo-thiepin derivatives and angiotensin converting enzyme (ACE) inhibitors. These compositions represent a novel therapeutic approach to thromboembolic disease in man.
    Type: Grant
    Filed: June 4, 1984
    Date of Patent: December 10, 1985
    Assignee: Merck & Co., Inc.
    Inventors: Chi-Chung Chan, Anthony W. Ford-Hutchinson